Matthew R Henn insider trades

Open-market stock purchases and sales by Matthew R Henn, See Remarks at Seres Therapeutics, Inc, from SEC Form 4 filings since May 15, 2025.

Recent trades

DateStockTradeValue
Aug 17, 2026MCRB Seres Therapeutics, IncSold$369
Aug 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
Aug 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
Aug 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
Jul 8, 2026MCRB Seres Therapeutics, IncBought (not open market)—
May 18, 2026MCRB Seres Therapeutics, IncSold$580
May 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
May 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
May 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
Mar 4, 2026MCRB Seres Therapeutics, IncBought (not open market)—
Feb 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
Feb 15, 2026MCRB Seres Therapeutics, IncSold$754
Feb 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
Feb 15, 2026MCRB Seres Therapeutics, IncBought (not open market)—
Nov 15, 2025MCRB Seres Therapeutics, IncSold$21.7K
Nov 15, 2025MCRB Seres Therapeutics, IncBought (not open market)—
Nov 15, 2025MCRB Seres Therapeutics, IncBought (not open market)—
Nov 15, 2025MCRB Seres Therapeutics, IncBought (not open market)—

Companies traded

  • MCRB Seres Therapeutics, Inc: 6 sales, last Aug 17, 2026

Get free alerts when Matthew R Henn files a new trade →